Qiagen (QGEN) Competitors $39.69 -0.11 (-0.28%) As of 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock QGEN vs. ONC, BNTX, TEVA, SMMT, ITCI, GMAB, MRNA, VTRS, RDY, and ASNDShould you be buying Qiagen stock or one of its competitors? The main competitors of Qiagen include Beigene (ONC), BioNTech (BNTX), Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Moderna (MRNA), Viatris (VTRS), Dr. Reddy's Laboratories (RDY), and Ascendis Pharma A/S (ASND). These companies are all part of the "pharmaceutical products" industry. Qiagen vs. Beigene BioNTech Teva Pharmaceutical Industries Summit Therapeutics Intra-Cellular Therapies Genmab A/S Moderna Viatris Dr. Reddy's Laboratories Ascendis Pharma A/S Qiagen (NYSE:QGEN) and Beigene (NASDAQ:ONC) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends, community ranking and institutional ownership. Which has preferable valuation and earnings, QGEN or ONC? Qiagen has higher earnings, but lower revenue than Beigene. Beigene is trading at a lower price-to-earnings ratio than Qiagen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQiagen$1.98B4.45$83.59M$0.36110.25Beigene$3.81B6.47-$881.71M-$6.14-40.79 Does the MarketBeat Community believe in QGEN or ONC? Qiagen received 246 more outperform votes than Beigene when rated by MarketBeat users. Likewise, 60.29% of users gave Qiagen an outperform vote while only 60.00% of users gave Beigene an outperform vote. CompanyUnderperformOutperformQiagenOutperform Votes24960.29% Underperform Votes16439.71% BeigeneOutperform Votes360.00% Underperform Votes240.00% Which has more risk and volatility, QGEN or ONC? Qiagen has a beta of 0.44, indicating that its stock price is 56% less volatile than the S&P 500. Comparatively, Beigene has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500. Do analysts prefer QGEN or ONC? Qiagen presently has a consensus price target of $47.71, indicating a potential upside of 20.20%. Beigene has a consensus price target of $310.00, indicating a potential upside of 23.77%. Given Beigene's stronger consensus rating and higher probable upside, analysts plainly believe Beigene is more favorable than Qiagen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qiagen 0 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.30Beigene 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders have more ownership in QGEN or ONC? 70.0% of Qiagen shares are held by institutional investors. Comparatively, 48.5% of Beigene shares are held by institutional investors. 9.0% of Qiagen shares are held by insiders. Comparatively, 7.4% of Beigene shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is QGEN or ONC more profitable? Qiagen has a net margin of 4.23% compared to Beigene's net margin of -25.94%. Qiagen's return on equity of 13.92% beat Beigene's return on equity.Company Net Margins Return on Equity Return on Assets Qiagen4.23% 13.92% 8.40% Beigene -25.94%-25.12%-14.95% Does the media refer more to QGEN or ONC? In the previous week, Qiagen and Qiagen both had 4 articles in the media. Qiagen's average media sentiment score of 0.96 beat Beigene's score of 0.51 indicating that Qiagen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qiagen 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Beigene 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryQiagen beats Beigene on 11 of the 16 factors compared between the two stocks. Remove Ads Get Qiagen News Delivered to You Automatically Sign up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QGEN vs. The Competition Export to ExcelMetricQiagenBiological Products IndustryMedical SectorNYSE ExchangeMarket Cap$8.81B$3.01B$5.67B$19.75BDividend YieldN/A1.54%4.55%3.75%P/E Ratio110.5229.8424.5934.06Price / Sales4.45447.65395.6328.49Price / Cash12.01168.6838.1617.54Price / Book2.474.207.054.63Net Income$83.59M-$71.72M$3.20B$1.02B7 Day Performance-0.14%-2.36%1.42%1.17%1 Month Performance-0.06%-9.73%5.77%-1.04%1 Year Performance-4.64%-22.71%14.93%7.12% Qiagen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QGENQiagen4.0428 of 5 stars$39.69-0.3%$47.71+20.2%-6.5%$8.81B$1.98B110.526,030Positive NewsONCBeigene1.2524 of 5 stars$265.07+2.3%$327.00+23.4%N/A$25.94B$3.81B-32.1710,600BNTXBioNTech3.2793 of 5 stars$100.86+1.4%$143.73+42.5%+9.6%$24.18B$2.75B-48.036,133TEVATeva Pharmaceutical Industries2.605 of 5 stars$16.74+2.5%$23.43+40.0%+16.5%$18.97B$16.54B-11.5436,800SMMTSummit Therapeutics2.3689 of 5 stars$20.13-3.2%$34.11+69.5%+513.9%$14.85B$700,000.00-71.89110ITCIIntra-Cellular Therapies3.6015 of 5 stars$131.45+0.1%$106.08-19.3%+90.8%$13.98B$680.50M-151.09560Positive NewsGMABGenmab A/S4.1658 of 5 stars$20.80+1.4%$41.33+98.7%-35.5%$13.76B$21.53B11.952,204MRNAModerna4.1029 of 5 stars$34.71+0.3%$59.60+71.7%-67.6%$13.39B$3.20B-3.743,900VTRSViatris1.9798 of 5 stars$9.25+1.6%$10.50+13.5%-21.5%$11.04B$14.74B-12.5037,000RDYDr. Reddy's Laboratories2.9487 of 5 stars$13.23+4.3%$17.00+28.5%-6.7%$11.04B$311.31B21.0624,800Gap UpASNDAscendis Pharma A/S3.0809 of 5 stars$168.84+10.4%$202.36+19.9%+15.8%$10.25B$363.64M-23.781,017News CoveragePositive NewsGap UpHigh Trading Volume Remove Ads Related Companies and Tools Related Companies ONC Alternatives BNTX Alternatives TEVA Alternatives SMMT Alternatives ITCI Alternatives GMAB Alternatives MRNA Alternatives VTRS Alternatives RDY Alternatives ASND Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:QGEN) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qiagen Please log in to your account or sign up in order to add this asset to your watchlist. Share Qiagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy QGEN Stock Free QGEN Stock Alerts